Bucks County Family Returns Home After Climbing Mt. Kilimanjaro to Raise Awareness About Ovarian Cancer CBS News News | Sep 21, 2023 After battling and overcoming ovarian cancer, Christine Hussey is no stranger to climbing mountains - literally! Christine made a goal of climbing Mount Kilimanjaro with her husband and twin sons to raise awareness for those affect by the disease. Latest News Positron Emission Tomography Imaging of Poly–(Adenosine Diphosphate–Ribose) Polymerase 1 Expression in Breast Cancer Journal of the American Medical Association News | April 2020 Basser scientists were part of this Penn Medicine team effort studying PARP-1 expression and breast cancer. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families Journal of Clinical Oncology News | April 2020 Basser Executive Director Susan Domchek, MD, and Basser Director of Genetics Katherine L. Nathanson, MD, were involved in this study to examine the risk of various cancers associated with the PALB2 genetic mutation. PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells Penn Today News | April 2020 Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness. Structural basis for allosteric PARP-1 retention on DNA breaks Science News | April 2020 Ben Black, PhD, a professor at Penn Medicine and Basser funded scientist, recently published a paper exploring the mechanisms of PARP binding, which looks to explain the difference in efficiency of the various PARP inhibitor cancer treatments. PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells Penn Today News | April 2020 Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness. Working on ‘the human side’ of heritable cancers Penn Today News | March 2020 How do you make major life decisions knowing you are likely to develop cancer? Allison Werner-Lin looks at these questions, studying the intersection of genetics and family life. Penn is fighting pancreatic cancer Penn Today News | March 2020 Researchers within the Penn Pancreatic Cancer Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer Nature News | February 2020 This paper in Genetics in Medicine is a collaborative effort between Penn Medicine, the Basser Center, and researchers across the country. It is the first large-scale report on the CTNNA1 gene, which may represent a risk factor for early-onset gastric cancer and possibly breast cancer. National BRCA Study Sees Lower Participation in Philly Jewish Exponent News | February 2020 The Jewish Exponent highlights the BFOR Study, which offers no-cost testing to men and women of Ashkenazi Jewish descent for BRCA gene mutations. Basser Executive Director Susan Domchek, MD, a principal investigator on the study, notes that the Philadelphia area is still open for enrollment. The Other Jewish Women’s Cancer Lilith Magazine News | February 2020 Lilith Magazine examined the genetic risk of ovarian cancer, especially in Jewish women, and interviewed Basser Executive Director Susan Domchek, MD, about prevention, screening, and treatment options. As Home Genetic Tests Flood Market, Are Physicians Being Left Behind? Medscape News | January 2020 Susan Domchek, MD, Executive Director of the Basser Center, discussed at-home genetic testing and whether or not patients who need these tests the most have access. The Reinterpretation of Genetic Tests Is Rare Wall Street Journal News | January 2020 In a letter to the editor in the Wall Street Journal, Basser’s Kara Maxwell, MD, PhD, and Susan Domchek, MD, responded to an article the paper recently published about genetic testing, pointing out that reinterpretation of a patient’s genetic testing results is an incredibly rare case. BRCA: Who Should Be Tested? Cancer Today News | December 2019 Cancer Today interviewed Susan Domchek, MD, Executive Director of the Basser Center, about BRCA screening, who should get tested, and who is being left out under current guidelines. Germline genetic testing for breast cancer: which patients? What genes? Nature News | December 2019 In this editorial for Nature, Basser Executive Director Susan Domchek, MD, discusses genetic testing and breast cancer - which patients should be tested and what genetic mutations they should be tested for. A Brighter Outlook for Metastatic Breast Cancer Cure Magazine News | November 2019 Payal D. Shah, MD, an assistant professor of Hematology-Oncology at Penn Medicine and a member of the Basser Center, spoke about new treatments that are letting people live longer and improving quality of life for some patients with metastatic breast cancer. Abramson Cancer Center Experts Take Part in NBC10/AACR Telethon NBC10 News | November 2019 Experts from Penn Medicine's Abramson Cancer Center, including Basser Genetic Counselor Dana Farengo Clark, MS, LCGC, answered questions about cancer from NBC10 Philadelphia viewers as part of a telethon in partnership with the American Association for Cancer Research. BRCA Rules Leave Patients Behind OncLive News | November 2019 New guidelines from USPSTF on BRCA genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk, according to critics of the update, including Basser’s Susan Domchek, MD. Event in Manhattan raises over $8.5 million for research on BRCA-related cancers ABC7 News | November 2019 The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers. Pagination First page« First Previous page‹‹ … Page3 Page4 Page5 Page6 Current page7 Page8 Page9 Page10 Page11 … Next page›› Last pageLast »
Bucks County Family Returns Home After Climbing Mt. Kilimanjaro to Raise Awareness About Ovarian Cancer CBS News News | Sep 21, 2023 After battling and overcoming ovarian cancer, Christine Hussey is no stranger to climbing mountains - literally! Christine made a goal of climbing Mount Kilimanjaro with her husband and twin sons to raise awareness for those affect by the disease.
Positron Emission Tomography Imaging of Poly–(Adenosine Diphosphate–Ribose) Polymerase 1 Expression in Breast Cancer Journal of the American Medical Association News | April 2020 Basser scientists were part of this Penn Medicine team effort studying PARP-1 expression and breast cancer.
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families Journal of Clinical Oncology News | April 2020 Basser Executive Director Susan Domchek, MD, and Basser Director of Genetics Katherine L. Nathanson, MD, were involved in this study to examine the risk of various cancers associated with the PALB2 genetic mutation.
PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells Penn Today News | April 2020 Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.
Structural basis for allosteric PARP-1 retention on DNA breaks Science News | April 2020 Ben Black, PhD, a professor at Penn Medicine and Basser funded scientist, recently published a paper exploring the mechanisms of PARP binding, which looks to explain the difference in efficiency of the various PARP inhibitor cancer treatments.
PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells Penn Today News | April 2020 Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.
Working on ‘the human side’ of heritable cancers Penn Today News | March 2020 How do you make major life decisions knowing you are likely to develop cancer? Allison Werner-Lin looks at these questions, studying the intersection of genetics and family life.
Penn is fighting pancreatic cancer Penn Today News | March 2020 Researchers within the Penn Pancreatic Cancer Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress.
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer Nature News | February 2020 This paper in Genetics in Medicine is a collaborative effort between Penn Medicine, the Basser Center, and researchers across the country. It is the first large-scale report on the CTNNA1 gene, which may represent a risk factor for early-onset gastric cancer and possibly breast cancer.
National BRCA Study Sees Lower Participation in Philly Jewish Exponent News | February 2020 The Jewish Exponent highlights the BFOR Study, which offers no-cost testing to men and women of Ashkenazi Jewish descent for BRCA gene mutations. Basser Executive Director Susan Domchek, MD, a principal investigator on the study, notes that the Philadelphia area is still open for enrollment.
The Other Jewish Women’s Cancer Lilith Magazine News | February 2020 Lilith Magazine examined the genetic risk of ovarian cancer, especially in Jewish women, and interviewed Basser Executive Director Susan Domchek, MD, about prevention, screening, and treatment options.
As Home Genetic Tests Flood Market, Are Physicians Being Left Behind? Medscape News | January 2020 Susan Domchek, MD, Executive Director of the Basser Center, discussed at-home genetic testing and whether or not patients who need these tests the most have access.
The Reinterpretation of Genetic Tests Is Rare Wall Street Journal News | January 2020 In a letter to the editor in the Wall Street Journal, Basser’s Kara Maxwell, MD, PhD, and Susan Domchek, MD, responded to an article the paper recently published about genetic testing, pointing out that reinterpretation of a patient’s genetic testing results is an incredibly rare case.
BRCA: Who Should Be Tested? Cancer Today News | December 2019 Cancer Today interviewed Susan Domchek, MD, Executive Director of the Basser Center, about BRCA screening, who should get tested, and who is being left out under current guidelines.
Germline genetic testing for breast cancer: which patients? What genes? Nature News | December 2019 In this editorial for Nature, Basser Executive Director Susan Domchek, MD, discusses genetic testing and breast cancer - which patients should be tested and what genetic mutations they should be tested for.
A Brighter Outlook for Metastatic Breast Cancer Cure Magazine News | November 2019 Payal D. Shah, MD, an assistant professor of Hematology-Oncology at Penn Medicine and a member of the Basser Center, spoke about new treatments that are letting people live longer and improving quality of life for some patients with metastatic breast cancer.
Abramson Cancer Center Experts Take Part in NBC10/AACR Telethon NBC10 News | November 2019 Experts from Penn Medicine's Abramson Cancer Center, including Basser Genetic Counselor Dana Farengo Clark, MS, LCGC, answered questions about cancer from NBC10 Philadelphia viewers as part of a telethon in partnership with the American Association for Cancer Research.
BRCA Rules Leave Patients Behind OncLive News | November 2019 New guidelines from USPSTF on BRCA genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk, according to critics of the update, including Basser’s Susan Domchek, MD.
Event in Manhattan raises over $8.5 million for research on BRCA-related cancers ABC7 News | November 2019 The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers.